PLEASE FIND BELOW THE 2018 FALL CONFERENCE AGENDA
Wednesday, October 16, 2019
8:00 AM - 8:30 AM
Registration, welcome coffee and networking
8:30 AM - 8:40 AM
Chairman's Opening Address
8:40 AM - 9:10 AM
US Patent Law Outlook: What Major Changes are on the 2020 Horizon, and will the US Ease Limits on Patent-Eligible Inventions?
9:30 AM - 9:50 AM

How to get a Biologics Product to Market

9:50 AM - 10:10 AM

Canadian Patent Legislation Update

10:10 AM - 10:40 AM
Best Practice in Patenting Precision Medicine
10:40 AM - 11:10 AM
Morning Coffee and Networking in the Exhibition Hall
11:10 AM - 11:40 AM

Addressing Second Medical Use Infringement

11:40 AM - 12:10 PM

What are the Main Challenges Facing the Global Patent System – and what can we do to Prepare for them?

  • Is the Existing IP System Fit for Purpose?
12:10 PM - 12:30 PM

When a Purchaser is Obligated to Keep an Invention Secret, Does Prior Art Cover the Sale and Prevent Subsequent Patenting? 

12:30 PM - 12:45 PM
Mayo v Athena: What’s Now the Future of Diagnostic Patents?
12:45 PM - 2:00 PM
Lunch and networking in the Exhibition Hall 
2:00 PM - 2:05 PM
Roundtable Discussion Groups 
 
Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 40-45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion, and ends with a moderator round-up of key findings, providing delegates with an insight into all eight topics.
 
SESSION 1 - PLEASE CHOOSE YOUR FIRST TABLE FROM THE FOLLOWING:
2:00 PM - 2:45 PM
Biologics & Biosimilars
CAR-T and other Immunotherapies
How do we Ensure Effective Protection of Antibodies?
IP considerations in Precision Medicine
Latest Developments in US Post Grant Proceedings
Life Sciences Patents Open Clinic: Solving in-house counsel challenges
Navigating the CRISPR patent and licensing landscape
Prior Art: Examining the Implications of Trade Secrets Protection

 
Strategies in Second Medical Use cases
Supplementary Protection Certificates
2:45 PM - 3:00 PM
SESSION 2 - PLEASE CHOOSE YOUR SECOND TABLE FROM THE FOLLOWING: 
2:45 PM - 3:30 PM
Biologics & Biosimilars
CAR-T and other Immunotherapies
How do we Ensure Effective Protection of Antibodies?
IP considerations in Precision Medicine
Latest Developments in US Post Grant Proceedings
Life Sciences Patents Open Clinic: Solving in-house counsel challenges
Navigating the CRISPR patent and licensing landscape
3:30 PM - 4:00 PM
Afternoon tea and networking in the Exhibiton Hall
4:00 PM - 4:20 PM
How do Business People Perceive IP Management and How can you Better Engage Internal Decision Makers with the IP Strategy Discussion and Day to Day Operations
4:20 PM - 4:50 PM
Innovative IP Strategies for Life Sciences: Best Practice in Managing Pharma and Biotech IP in the Age of Big Data and Precision Medicine
4:50 PM - 5:10 PM
Enhancing Patent Strategy with Data Analytics
5:10 PM - 5:45 PM

IP Portfolio Management: In-house Counsel Day-to-Day Challenges in Prosecuting and Enforcing Patents

5:45 PM
Chair’s Closing Remarks

Contact our team

For sponsoring: 
Kirsty Pocock
Commercial Director
+44 (0) 203 301 8211
 
 
For speaking: 
Sarah Gooding 
Head of Content
sgooding@newtonmedia.co.uk
+44 (0) 7957672202
For attending: 
Kate Wood
Delegate Sales Manager
+44 (0) 203 301 8232